A comparative analysis of upadacitinib monotherapy and upadacitinib combination therapy for the treatment of rheumatoid arthritis from two

被引：0
|
作者：
Andrea, Rubbert-Roth
Maya, Buch H. [1 ,2 ]
Alvin, Wells F. [3 ]
Manish, Jain [4 ]
Casey, Schlacher [5 ]
Heidi, Camp S. [5 ]
Li Yihan [6 ]
Song Yanna [5 ]
Peter, Nash [6 ]
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] NIHR Biomed Res Ctr, Leeds, W Yorkshire, England
[3] Rheumatol & Immunotherapy Ctr, Franklin, WI USA
[4] Great Lakes Clin Trials, Rheumatol, Chicago, IL USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Univ Queensland, Brisbane, Qld, Australia
来源：
SWISS MEDICAL WEEKLY | 2019年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 8
引用
收藏
页码：8S / 8S
页数：1
相关论文
共 50 条
  • [41] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Nash, Peter
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 46
  • [42] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 323 - 324
  • [43] Sustainability of Response to Upadacitinib as Monotherapy or in Combination Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Conventional Synthetic DMARDs
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [44] Upadacitinib in rheumatoid arthritis: a profile of its use
    Duggan, Sean
    Keam, Susan J.
    DRUGS & THERAPY PERSPECTIVES, 2020, 36 (11) : 485 - 493
  • [45] Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review
    Sanmarti, Raimon
    Corominas, Hector
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [46] Upadacitinib in rheumatoid arthritis: a profile of its use
    Sean Duggan
    Susan J. Keam
    Drugs & Therapy Perspectives, 2020, 36 : 485 - 493
  • [47] Hematological Impact Assessment of Tofacitinib, Baricitinib, and Upadacitinib in Rheumatoid Arthritis Treatment
    Ahn, Soo Min
    Cho, Mi-Ra
    Oh, Ji Seon
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1061 - 1064
  • [48] The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritis
    Avci, Ali Berkant
    Feist, Eugen
    Burmester, Gerd Rudiger
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [49] Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis
    Çalgüneri, M
    Pay, S
    Çaliskaner, Z
    Apras, S
    Kiraz, S
    Ertenli, I
    Çobankara, V
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : 699 - 704
  • [50] Use of upadacitinib in the treatment of psoriatic arthritis
    Ross, Yael
    Magrey, Marina
    IMMUNOTHERAPY, 2021, 13 (18) : 1549 - 1554
12345